Effect of Two-Year Caloric Restriction on Bone Metabolism and Bone Mineral Density in Non-Obese Younger Adults: A Randomized Clinical Trial Article

Industry Collaboration International Collaboration

cited authors

  • Villareal, Dennis T., Fontana, Luigi, Das, Sai Krupa, Redman, Leanne, Smith, Steven R., Saltzman, Edward, Bales, Connie, Rochon, James, Pieper, Carl, Huang, Megan, Lewis, Michael, Schwartz, Ann V., CALERIE Study Grp

funding text

  • This study was supported by the National Institute on Aging (NIA) and National Institute of Diabetes and Kidney Diseases, National Institutes of Health (U01AG022132, U01AG020478, U01AG020487, U01AG020480, and U24AG047121). Consistent with an NIH cooperative agreement, the study was designed and managed by a Steering Committee consisting of the Principal Investigators of the three clinical sites and the Data Coordinating Center and a representative from the NIA. Decisions were made by majority vote, and all members, including the NIH, had one vote. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Aging or the National Institutes of Health.

abstract

  • Although caloric restriction (CR) could delay biologic aging in humans, it is unclear if this would occur at the cost of significant bone loss. We evaluated the effect of prolonged CR on bone metabolism and bone mineral density (BMD) in healthy younger adults. Two-hundred eighteen non-obese (body mass index [BMI] 25.1 +/- 1.7 kg/m(2)), younger (age 37.9 +/- 7.2 years) adults were randomly assigned to 25% CR (CR group, n = 143) or ad libitum (AL group, n = 75) for 2 years. Main outcomes were BMD and markers of bone turnover. Other outcomes included body composition, bone-active hormones, nutrient intake, and physical activity. Body weight (-7.5 perpendicular to 0.4 versus 0.1 perpendicular to 0.5 kg), fat mass (-5.3 perpendicular to 0.3 versus 0.4 perpendicular to 0.4 kg), and fat-free mass (-2.2 perpendicular to 0.2 versus -0.2 perpendicular to 0.2 kg) decreased in the CR group compared with AL (all between group p < 0.001). Compared with AL, the CR group had greater changes in BMD at 24 months: lumbar spine (-0.013 +/- 0.003 versus 0.007 +/- 0.004 g/cm(2); p < 0.001), total hip (-0.017 +/- 0.002 versus 0.001 +/- 0.003 g/cm(2); p < 0.001), and femoral neck (-0.015 +/- 0.003 versus -0.005 +/- 0.004 g/cm(2); p = 0.03). Changes in bone markers were greater at 12 months for C-telopeptide (0.098 +/- 0.012 versus 0.025 +/- 0.015 mu g/L; p < 0.001), tartrate-resistant acid phosphatase (0.4 +/- 0.1 versus 0.2 +/- 0.1 U/L; p = 0.004), and bone-specific alkaline phosphatase (BSAP) (-1.4 +/- 0.4 versus -0.3 +/- 0.5 U/L; p = 0.047) but not procollagen type 1 N-propeptide; at 24 months, only BSAP differed between groups (-1.5 +/- 0.4 versus 0.9 +/- 0.6 U/L; p = 0.001). The CR group had larger increases in 25-hydroxyvitamin D, cortisol, and adiponectin and decreases in leptin and insulin compared with AL. However, parathyroid hormone and IGF-1 levels did not differ between groups. The CR group also had lower levels of physical activity. Multiple regression analyses revealed that body composition, hormones, nutrients, and physical activity changes explained similar to 31% of the variance in BMD and bone marker changes in the CR group. Therefore, bone loss at clinically important sites of osteoporotic fractures represents a potential limitation of prolonged CR for extending life span. Further long-term studies are needed to determine if CR-induced bone loss in healthy adults contributes to fracture risk and if bone loss can be prevented with exercise. (C) 2015 American Society for Bone and Mineral Research.

Publication Date

  • January 1, 2016

webpage

published in

category

start page

  • 40

end page

  • 51

volume

  • 31

issue

  • 1

WoS Citations

  • 39

WoS References

  • 54